retatrutide glp-1 gip glucagon receptor agonist Retatrutide Before and After: Doctor Reveals Real Results Retatrutide—A Game Changer in Obesity
Description
pediatric patients
Provide a complete list of all medications, supplements, and over-the-counter products you take
Not the fastest ramp
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists
For Canadian patients particularly, the conversation around medication dependency carries unique weight given our universal healthcare culture that emphasizes prevention and lifestyle
Treatment areas Holistic care focused on restoring optimal function and wellness
